Press release
Type 1 Diabetes Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects, and Key Companies
Type 1 Diabetes Overview
Type 1 diabetes is an autoimmune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. It is not known what causes this autoimmune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented.
"Type 1 Diabetes Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Type 1 Diabetes Market.
The Type 1 Diabetes Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Type 1 Diabetes Pipeline Report: https://www.delveinsight.com/report-store/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Type 1 Diabetes treatment therapies with a considerable amount of success over the years. Type 1 Diabetes Key players such as - Arecor, Novo Nordisk, Novartis, ILTOO Pharma, ImCyse, Zealand Pharma, Eli Lilly and Company, Dompe Farmaceutici, Provention Bio, and others, are developing therapies for the Type 1 Diabetes treatment
• Type 1 Diabetes Emerging therapies such as - AT247, NNC0471-0119, MHS552, ILT-101, IMCY-0098, Iscalimab, Dasiglucagon, LY3209590, Ladarixin, Teplizumab, and others are expected to have a significant impact on the Type 1 Diabetes market in the coming years.
• In April 2019, Provention Bio initiated a Phase 3, randomized, double-blind, placebocontrolled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, antiCD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently diagnosed with type 1 diabetes(within 6 weeks of diagnosis)
• On June 30, 2022, Provention Bio announced that the U.S. Food and Drug Administration (FDA) extended its review period by three months for the BLA for teplizumab
Type 1 Diabetes Pipeline Therapeutics Assessment
• Type 1 Diabetes Assessment by Product Type
• Type 1 Diabetes By Stage and Product Type
• Type 1 Diabetes Assessment by Route of Administration
• Type 1 Diabetes By Stage and Route of Administration
• Type 1 Diabetes Assessment by Molecule Type
• Type 1 Diabetes by Stage and Molecule Type
DelveInsight's Type 1 Diabetes Report covers around 100+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Type 1 Diabetes Drugs Under Different Phases of Clinical Development Include:
• AT247: Arecor
• NNC0471-0119: Novo Nordisk
• MHS552: Novartis
• ILT-101: ILTOO Pharma
• IMCY-0098: ImCyse
• Iscalimab: Novartis
• Dasiglucagon: Zealand Pharma
• LY3209590: Eli Lilly and Company
• Ladarixin: Dompe Farmaceutici
• Teplizumab: Provention Bio
Get a Free Sample PDF Report to know more about Type 1 Diabetes Pipeline Assessment- https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Type 1 Diabetes Pipeline Analysis:
The Type 1 Diabetes pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Type 1 Diabetes treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Type 1 Diabetes Treatment.
• Type 1 Diabetes key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Type 1 Diabetes Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Type 1 Diabetes market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Type 1 Diabetes product details are provided in the report. Download the Type 1 Diabetes pipeline report to learn more about the emerging Type 1 Diabetes therapies at:
https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Type 1 Diabetes Pipeline Market Drivers
• Rising prevalence of type-1 diabetes due to environmental and genetic factors
• Growing geriatric population, which is susceptible to type-1 diabetes
• Increasing prevalence of obesity, which is a contributing factor
Type 1 Diabetes Pipeline Market Barriers
• Lack of awareness among patients regarding types of treatment available
• Strict approval process and side effects associated with the treatment may restrict market growth
Scope of Type 1 Diabetes Pipeline Drug Insight
• Coverage: Global
• Key Type 1 Diabetes Companies: Landos Biopharma, Diamyd Medical, Gan & Lee Pharmaceuticals, Zealand Pharma, Kamada, AstraZeneca, Novo Nordisk, Provention Bio Preregistration, Histogen, Vertex Pharmaceuticals, Panbela Therapeutics, Arecor, Bioprojet, Novartis, ImCyse, Adocia, Anelixis Therapeutics, Tolerion, TikoMed, Avotres, REMD Biotherapeutics, Novo Nordisk, and others
• Key Type 1 Diabetes Therapies: AT247, NNC0471-0119, MHS552, ILT-101, IMCY-0098, Iscalimab, Dasiglucagon, LY3209590, Ladarixin, Teplizumab, and others
• Type 1 Diabetes Therapeutic Assessment: Type 1 Diabetes current marketed and Type 1 Diabetes emerging therapies
• Type 1 Diabetes Market Dynamics: Type 1 Diabetes market drivers and Type 1 Diabetes market barriers
Request for Sample PDF Report for Type 1 Diabetes Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Type 1 Diabetes Report Introduction
2 Type 1 Diabetes Executive Summary
3 Type 1 Diabetes Overview
4 Type 1 Diabetes- Analytical Perspective In-depth Commercial Assessment
5 Type 1 Diabetes Pipeline Therapeutics
6 Type 1 Diabetes Late Stage Products (Phase II/III)
7 Type 1 Diabetes Mid Stage Products (Phase II)
8 Type 1 Diabetes Early Stage Products (Phase I)
9 Type 1 Diabetes Preclinical Stage Products
10 Type 1 Diabetes Therapeutics Assessment
11 Type 1 Diabetes Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Type 1 Diabetes Key Companies
14 Type 1 Diabetes Key Products
15 Type 1 Diabetes Unmet Needs
16 Type 1 Diabetes Market Drivers and Barriers
17 Type 1 Diabetes Future Perspectives and Conclusion
18 Type 1 Diabetes Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Type 1 Diabetes drugs and therapies- https://www.delveinsight.com/sample-request/type-1-diabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Type 1 Diabetes Market https://www.delveinsight.com/report-store/type-1-diabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Type 1 Diabetes-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom).
Type 1 Diabetes Epidemiology https://www.delveinsight.com/report-store/type-1-diabetes-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Type 1 Diabetes Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Trending Reports:
Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology, and the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Filgrastim Biosimilar Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027.
To know more about our Competitive Services, Click here:
https://www.delveinsight.com/consulting/competitive-intelligence-services?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Type 1 Diabetes Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Growth Prospects, and Key Companies here
News-ID: 2759502 • Views: …
More Releases from DelveInsight Business Research
Lassa Fever Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapie …
DelveInsight's "Lassa Fever - Pipeline Insight, 2025" provides a detailed view of the evolving pipeline, emphasizing efforts to deliver first-in-class therapies and vaccines to endemic populations. The report highlights global R&D activity, platform technologies, and regulatory incentives accelerating development timelines.
Lassa Fever, an acute viral hemorrhagic disease endemic to West Africa, remains a serious public health challenge due to recurrent outbreaks and limited treatment options. Despite high fatality rates in severe…
Hunter Syndrome Market Outlook 2034 - Clinical Trials, Market Size, Medication, …
Hunter Syndrome Market Summary
In 2023, the US held the largest Hunter Syndrome market share among the 7MM, with around 500 prevalent cases. Current treatments include enzyme replacement therapy (ERT), hematopoietic stem cell transplantation (HSCT), and bone marrow transplantation (BMT). The only FDA-approved therapy is ELAPRASE, while IZCARGO and HUNTERASE ICV are approved in Japan. However, existing treatments do not address the cognitive symptoms, as ERTs cannot cross the blood-brain barrier.…
Global Injectable Drug Delivery Devices Market to grow at a CAGR of 11.26% by 20 …
According to DelveInsight's analysis, The growth in demand for injectable drug delivery devices is largely driven by the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders, the increasing adoption of self-injectors, expansion of the biologics and biosimilars market, the growing emphasis on patient compliance with treatments, and continuous innovations and technological advancements in the field.
DelveInsight's "Injectable Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2030" report…
Abdominal Aortic Aneurysm Market Expected to Gain Momentum Through 2034, Accordi …
DelveInsight's "Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm…
More Releases for Type
Pressure Pumping Market 2028 By Type, Well Type, Resource Type and Geography
The Insight Partners delivers well-researched industry-wide information on the Pressure Pumping market. It provides information on the market's essential aspects such as top participants, factors driving Pressure Pumping market growth, precise estimation of the Pressure Pumping market size, upcoming trends, changes in consumer behavioral pattern, market's competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market. Additionally, the report is a compilation of…
Lawn Mowers Market Analysis By Type, End User, Product Type, Fuel Type, Engine P …
Lawn Mowers Market Analysis By Type(Manual, Electric, Petrol, Robotic), By End User(Residential, Commercial), By Product Type(Walk behind Movers, Ride on Movers, Stand on Movers), By Fuel Type(Gas Powered, Propane Powered), By Engine Power(Less than 15 hp, Between 15hp and 30 hp, More than 30 hp), By Blade Type(Cylinder, Standard, Mulching, Lifting), By Drive Type(AWD, FWD, RWD), By Application(Residential, Professional landscaping, Golf Course, Government), By Distribution Channel(Retail Store, Online Website) &…
Automotive Exhaust System Component Market Type, Fuel Type, Treatment Device, Ve …
Automotive Exhaust System Component Market
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Tenneco
Faurecia
Eberspacher
Boysen
Sango
HITER
Yutaka Giken
Calsonic Kansei
Magneti Marelli
Benteler
Sejong Industrial
Katcon
Futaba
Wanxiang
Bosal
Harbin Airui
Dinex
Catar
DSM
Get Sample PDF including full TOC, Tables and Figures @ https://www.ozonemarketreports.com/automotive-and-transportation/global-automotive-exhaust-system-components-market-professional-survey-report-2019/59563
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Exhaust Manifold
Exhaust Pipe
Catalytic Converter
Exhaust Temperature Sensor
Car Muffler
Exhaust…
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,…
Automotive Electric Vacuum Pump Market By Type Diaphragm Type, Swing Piston Type …
Automatic electric vacuum pump is a device that gets the drive from the camshaft in the engine. It can also be run by alternator shaft in some designs. It’s an added benefit to any engine, which has high performance. The primary function of an automatic electric vacuum pump is to drain out the air from brake booster tank hence creating the vacuum, which in turn can be used for application…
Marine Composites Market |By Type |Resin Type|Vessel Type|Fiber Type |Region Ana …
The report includes market segmentation by composites type (metal matrix composite, ceramic matrix composite, polymer matrix composite); polymer matrix composite by fiber type (glass fiber, carbon fiber, others); polymer matrix composite by resin type (polyester, vinyl ester, epoxy, thermoplastic, others); vessel type (power boats, sailboats, cruise ships, others); and region (North America, Europe, APAC, Latin America, MEA).
Download Latest Free PDF Sample Brochure of “Marine Composites Market” With Detailed TOC…
